Home Cart Sign in  
Chemical Structure| 1308631-40-4 Chemical Structure| 1308631-40-4

Structure of NDMC101
CAS No.: 1308631-40-4

Chemical Structure| 1308631-40-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NDMC101 is a potent osteoclastogenesis inhibitor and inhibits osteoclast differentiation via down-regulation of NFATc1-modulated gene express. NDMC101 is similar to the DPP4 substrate and is a significant inhibitor of early T-cell activation via DPP4 inhibition. NDMC101can be used for study of bone disorders, such as rheumatoid arthritis, and synovial inflammation et al .

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NDMC101

CAS No. :1308631-40-4
Formula : C13H9ClFNO2
M.W : 265.67
SMILES Code : O=C(NC1=CC=C(Cl)C=C1F)C2=CC=CC=C2O
MDL No. :MFCD13200880

Safety of NDMC101

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H303-H315-H319-H335-H401
Precautionary Statements:P261-P264-P271-P273-P280-P280-P302+P352-P304+P340+P312-P305+P351+P338-P312-P332+P313-P337+P313-P362+P364-P403+P233-P405-P501

Related Pathways of NDMC101

pyroptosis

Isoform Comparison

Biological Activity

Description
NDMC101 effectively suppresses osteoclastogenesis by reducing osteoclast differentiation through the downregulation of NFATc1-mediated gene expression. It mimics the DPP4 substrate, significantly hindering early T-cell activation by inhibiting DPP4. NDMC101 is suitable for researching bone conditions, including rheumatoid arthritis and synovial inflammation, among others[1].
Target
  • JNK

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.76mL

0.75mL

0.38mL

18.82mL

3.76mL

1.88mL

37.64mL

7.53mL

3.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories